Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
3-Iodobenzylamine, 97%, Thermo Scientific Chemicals
Click to view available options
Quantity:
1 g
5 g
Description
It is a pharmaceutical intermediate.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Applications
It is a pharmaceutical intermediate.
Solubility
Difficult to mix in water.
Notes
Air sensitive and light sensitive. Store in cool dry conditions in well sealed containers. Incompatible with strong oxidizing agents.
It is a pharmaceutical intermediate.
Solubility
Difficult to mix in water.
Notes
Air sensitive and light sensitive. Store in cool dry conditions in well sealed containers. Incompatible with strong oxidizing agents.
Specifications
Density | 1.748 |
Boiling Point | 132°C (8 mmHg) |
Flash Point | >110°C (230°F) |
Refractive Index | 1.6375 |
Quantity | 1 g |
UN Number | UN2735 |
Beilstein | 2689602 |
Sensitivity | Air and light sensitive |
Solubility Information | Difficult to mix in water. |
Formula Weight | 233.05 |
Show More |
Safety and Handling
Hazard Category | H314 |
Hazard Statement | GHS H Statement H314-H318 Causes severe skin burns and eye damage. Causes serious eye damage. |
Precautionary Statement | P260-P264b-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P363-P501c |
DOTInformation | Hazard Class: 8; Packaging Group: III |
TSCA | No |
Recommended Storage | Ambient temperatures |
RUO – Research Use Only
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction